Trade AbbVie ^ABBV

Why AbbVie's next wave of blockbuster drugs has me buying the stock

Pharmaceutical Stocks To Research - October 27th - Zolmax

Biotech Stocks To Watch Now - October 27th - Markets Daily

AbbVie Inc. $ABBV Shares Newly Bought by Sunesis Advisors LLC - Zolmax

2,729 AbbVie Inc. $ABBV Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA - Markets Daily

AbbVie Submits FDA Application For Etentamig In Multiple Myeloma

Geneva Partners LLC Makes New $3.12 Million Investment in AbbVie Inc. $ABBV - Zolmax

Oppenheimer & Co. Inc. Buys 14,115 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Purchased by Verdence Capital Advisors LLC

Sunesis Advisors LLC Acquires 9,159 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Miller Howard Investments Inc. NY

Leo Wealth LLC Acquires New Shares in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Newly Bought by Geneva Partners LLC

10,800 AbbVie Inc. $ABBV Shares Sold by Hourglass Capital LLC - Markets Daily

Hourglass Capital LLC Sells 10,800 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Hilton Head Capital Partners LLC

Baveno VIII refines the continuum of advanced chronic liver disease and portal hypertension

How Do You Tell a Yield Trap From a Real $6,400-a-Month Dividend Portfolio?

AbbVie Options Price In a Sudden 5% Swing-What Investors Must Know Before Oct. 30

AbbVie Inc. $ABBV Stake Lowered by Robeco Schweiz AG

2,429 AbbVie Inc. $ABBV Shares Sold by Robeco Schweiz AG

AbbVie Inc. $ABBV Stock: Total Wealth Planning & Management Inc. Trims Position

4,457 AbbVie Inc. $ABBV Shares Acquired by Simplicity Wealth LLC

3,545 AbbVie Inc. $ABBV Shares Purchased by IRON Financial LLC

BG Investment Services LLC Acquires 6,371 Shares of AbbVie Inc. $ABBV

Avalo Therapeutics (NASDAQ:AVTX) Stock Gets Price Target Trim from Wedbush - Zolmax

Avalo Therapeutics (NASDAQ:AVTX) Stock Gets Price Target Reduction from BTIG Research - Markets Daily

Erste Group Bank Has Negative View of AbbVie FY2027 Earnings

AbbVie Inc. $ABBV Shares Sold by Middleton & Co. Inc. MA - Daily Political

Teva (TEVA) Gets a Buy from Piper Sandler

AbbVie Inc. $ABBV Stake Boosted by One Wealth Capital Management LLC - Zolmax

AbbVie Inc. $ABBV Holdings Raised by One Wealth Capital Management LLC

AbbVie Inc. $ABBV Stake Lessened by Sterling Capital Management LLC

AbbVie Inc. $ABBV Stock: Evergreen Capital Management LLC Grows Stake

AbbVie Inc. $ABBV Stock Sold by Capital Investment Advisors LLC

AbbVie Inc. $ABBV Holdings Lessened by Wedbush Securities Inc. - Stock Observer

AbbVie Inc. $ABBV Stock Position Boosted by Royal Fund Management LLC

AbbVie Inc. $ABBV Stock: Sepio Capital LP Boosts Position

49,252 Shares in AbbVie Inc. $ABBV Bought by NBT Bank N.A.

AbbVie Inc. $ABBV Stock Bought by Root Financial Partners LLC - Daily Political

AbbVie Inc. (NYSE:ABBV) Stock Has Average Price Target of $279.86

AbbVie's Dividend Survived Humira's Patent Cliff. Will Merck and Amgen's?

Forget Chasing 7% Yields: These 5 Dividend Stocks Offer Something Different

AbbVie FY2026 Earnings Forecast Lowered by Erste Group Bank

ADARx Pharmaceuticals (ADRX): Can Its SiRNA Pipeline Unlock Multiple Growth Opportunities?

AbbVie Inc. $ABBV Stock Acquired by Crescent Grove Advisors LLC - Markets Daily

AbbVie Inc. $ABBV Stock: Lmcg Investments LLC Decreases Stake - Markets Daily

AbbVie Inc. $ABBV Stock Sold by Lmcg Investments LLC

AbbVie Inc. $ABBV Stock Sold by Vest Financial LLC

6,790 AbbVie Inc. $ABBV Shares Sold by AMF Tjanstepension AB

AbbVie's Lutikizumab Demonstrates Efficacy in Treating Hidradenitis Suppurativa, Paving Way for Weight-Loss Drug Combination, ETPharma

AbbVie (ABBV) Projected to Announce Quarterly Earnings on Friday

Ophthalmology Sector Emerges as Must-Win Battleground for Global Pharma: Eli Lilly, Merck & Co., AbbVie, Innovent Biologics, Hengrui Medicine and Leading Players Enter the Market

AbbVie Inc. $ABBV Stock Holdings Lessened by Investment House LLC - Stock Observer

Top Biotech Stocks To Consider - October 22nd - Markets Daily

AbbVie (ABBV) Reports Positive INTREPID Trial Results but Faces

AbbVie's Lutikizumab Meets Pre-specified Endpoints In Phase 3 Hidradenitis Suppurativa Trial

Jim Cramer and Ken Fisher Like This Healthcare Stock

JNJ Stock Has a New Growth Story, but One Business Needs to Catch Up

AbbVie Inc. $ABBV Stock Acquired by Sowell Financial Services LLC

Sawyer & Company Inc Purchases New Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Nisa Investment Advisors LLC

Crossmark Global Holdings Inc. Purchases 13,446 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Newly Purchased by Capstone Capital Management Ltd

2,400 AbbVie Inc. $ABBV Shares Purchased by Newman Dignan & Sheerar Inc. - Stock Observer

Sowell Financial Services LLC Buys 3,985 Shares of AbbVie Inc. $ABBV - Daily Political

Multiple myeloma in the Netherlands: 35-year trends in incidence and survival

Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial

Alpha male in HS? Abbvie phase III data subdue Avalo shares​ | BioWorld

AbbVie's HArmonyCa Shows Midface Improvement In GLP-1 Patient Analysis; Stock Down

AbbVie vs. AstraZeneca: Which Pharma Giant Has the Stronger Earnings Growth Story?

AbbVie Highlights New HArmonyCa Results In Patients Using GLP-1 Weight-Loss Drugs

Forget Social Security: 5 High-Yield Stocks Retirees Are Buying Instead

AbbVie reaches agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for ELAHERE® in Platinum-Resistant Ovarian Cancer

Top 10 Stocks Jim Cramer and Billionaire Ken Fisher Like

3,811 AbbVie Inc. $ABBV Shares Sold by Prime Capital Investment Advisors LLC

AbbVie Inc. $ABBV Stock Sold by Sumitomo Mitsui DS Asset Management Company Ltd

AbbVie Inc. $ABBV Stock: Bank Pictet & Cie Europe AG Reduces Position

Biotech Stocks To Keep An Eye On - October 18th - Stock Observer

Top Global Life Science Funds 2024: Unprecedented Massive Funding Surge Creates Excess Capital Overflow

McLaren Teams Up With AbbVie Before Formula 1 United States GP At COTA

AbbVie (ABBV) Posts Fresh Crohn's Remission Data Ahead Of Its Biggest ESMO Reveal

AbbVie's SKYRIZI Gets Health Canada Approval For Children With Moderate To Severe Plaque Psoriasis

AbbVie (ABBV) - Investment Analysts' Recent Ratings Updates - Daily Political

Pharmaceutical Stocks To Consider - October 20th - Daily Political

Greg Jennings LLC Makes New Investment in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Stock Holdings Cut by RWQ Financial Management Services Inc.

AbbVie (ABBV) Receives a Buy from RBC Capital

Parkinson's Disease Pipeline Landscape 2026: Late-Stage Candidates, MOA Trends, and ROA by DelveInsight | AbbVie, Pfizer, Novartis, F. Roche, Kissei Pharma, AstraZeneca, Prevail Therapeutics, Amneal | ABNewswire

AbbVie Inc. $ABBV Stock: Gimbal Financial Boosts Position

AbbVie Inc. $ABBV Stock Holdings Trimmed by BDF Gestion

AbbVie (ABBV) Unveils Phase 2a Crohn's Data And Flags 2026 ESMO Readouts

AbbVie vs. Bristol Myers: Is AbbVie's Valuation Premium Worth Paying?

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Week Ahead: China Is On Holiday, But The BoC, The Fed, And The ECB Will Be Busy With The First 2025 Rate Announcements 

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Fed, ECB & BoJ in action

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk